TABLE 1

Measured concentrations of ADX88178 in mice and rats at the end of experiments

TreatmentSpeciesRouteDosenMean Plasma Exposure
mg/kgng/ml
EPMa
 ADX88178Micep.o.11010
 ADX88178Micep.o.310229
 ADX88178Micep.o.10101287
 ADX88178Micep.o.30102865
 ADX88178Ratsp.o.10101129
 ADX88178Ratsp.o.30102295
 ADX88178Ratsp.o.100103513
MBb
 ADX88178Micep.o.31022
 ADX88178Micep.o.1010541
 ADX88178Micep.o.30101619
 ADX88178Micep.o.100104395
FSTc
 ADX88178Micep.o.310167
 ADX88178Micep.o.10101776
 ADX88178Micep.o.30102994
 ADX88178Micep.o.100106028
DOId
 ADX88178Micep.o.3833
 ADX88178Micep.o.108338
 ADX88178Micep.o.3081146
MK-801e
 ADX88178Micep.o.31023
 ADX88178Micep.o.1010133
 ADX88178Micep.o.3010624
CARf
 ADX88178Ratsp.o.18106
 ADX88178Ratsp.o.38408
 ADX88178Ratsp.o.1081273
 ADX88178Ratsp.o.3083030
  • a Plasma sample taken from all ADX88178-treated animals approximately 65 minutes postadministration.

  • b Plasma sample taken from all ADX88178-treated animals approximately 90 minutes postadministration.

  • c Plasma sample taken from all ADX88178-treated animals approximately 66 minutes postadministration.

  • d Plasma sample taken from all ADX88178-treated animals approximately 66 minutes postadministration.

  • e Plasma sample taken from all ADX88178-treated animals approximately 120 minutes postadministration.

  • f Plasma sample taken from all ADX88178-treated animals approximately 70 minutes postadministration.